Return to program book search
Tuesday, March 05
1:00 PM - 3:00 PM
Adnan Nasir, MD, PhD, FAAD - Handout
- Richard Rox Anderson, MD, FAAD
- Adam J. Friedman, MD, FAAD
- Sancy A. Leachman, MD, PhD, FAAD
- Howard Ira Maibach, MD, FAAD
- Steven Q. Wang, MD, FAAD
- Michael G. Wilkerson, MD, FAAD
Following this course, the attendee should be able to:
- Define nanotechnology as it applies to dermatology.
- Identify the key developments in nanotechnology for the diagnosis and management of skin disease and the maintenance of skin health.
- Recognize safety and regulatory issues related to nanotechnology.
Nanotechnology is a rapidly growing field with enormous implications for consumers, patients, and medicine. The interest in nanotechnology and skin care is expected to burgeon. A substantial proportion of nanotechnology-based discoveries are already in the realm of cosmetics, consumer skin care products, and cutaneous drug delivery. Matter made at the nanoscale possesses unique properties. These properties permit the design of agents with specificity, adaptability, and targeted therapy. Furthermore, nanomaterials can be engineered to eliminate undesirable qualities. This session aims to introduce attendees to consumer, diagnostic, and therapeutic aspects of nanotechnology as they relate to dermatology.